Paul Charles M. Piette

PharmD. Senior Research Fellow. Medical Science Expert.

WORK EXPERIENCE
• Medical Science Expert
• Global Medical Team, Besins Healthcare (since 2001)
• Faculty member and lecturer at PREIS School (Permanent International and European
School in Perinatal, Neonatal and Reproductive Medicine)– Florence – Italy (since 2012).
• Faculty memeber and lecturer at PRISM School (Post-Graduate International of Men’s
Health School)– Bruges – Belgium (since 2013).
• Senior Research Fellow - Besins Healthcare Global R&D (December 2007)
• Scientific & Medical Affairs Director of Besins Healthcare Global (2006)
• Medical Director of Besins Healthcare Benelux (2001)
• Permanent clinical expert consultant for Besins Healthcare Global since 2001
• Pharmacist agreed by Federal Agency for Medicines and Health Products, famhp in
Belgium for pharmacovigilance (P244)
• Medico-Marketing Director of Besins International Healthcare, Head of Regulatory
Corporate Affairs (from 2003 to 2006)
• Associated Pharmacist responsible for QA in Besins International Belgium (1997-2001)
• Effective Member of National Committee of Clinical Biology (1996–2000)
• Master of training Courses at the Free University of Brussels for Clinical Chemistry and
Endocrinology since 1991
• Consultant at Clinique Antoine Depage – Brussels – Belgium (from 2001) and Honorary
Head of Clinical Laboratory Department
• Director and CEO of Laboratoire d'Analyses Médicales (Labopiette S.P.R.L.), Chief of
Blood Analysis Department and Laboratories of Clinique Antoine Depage from 1982 to
2001
• Director and CEO of Laboratoire d'Analyses Médicales Piette & Stallenberg SPRL from
1978 to 1982
• Associated Industrial Pharmacist of Laboratoires Piette Internatonal s.a.
(Manufacturing plant), agreed by Belgian Ministry of Public Health, since 1982 (AFMPS
Agr.number 902)
• Consultant of Sopropharm s.a.(Edition and Medical Promotion Company), from 1985 to
2001
• Board of Directors & Medical Director of Besins International Belgium s.a., before
Laboratoires Piette International s.a. (1977-2001)
PROFESSIONAL QUALIFICATIONS
• KOLs management in men’s and women’s health (since 2001)
• Faculty and speaker at International PREIS Academy International School – Florence –
Italy (since 2012).
• Faculty and speaker at PRISM Post-Graduate International of Men’s Health School
(School) -Bruges – Belgium (since 2013).
• Expert and speaker at International Women’s and Men’s Health meetings (ISGE, COGI,
IMS…).
• Scientific & Medical Affairs Director of Besins Healthcare Corporate (since 2006)
• Scientific and Medical Director of Besins Healthcare Benelux (since 1977) – North
Europe (since 2006)
• CEO of BIOCLIN Consulting and Marketing SPRL, consulting company involved in
Medical and Marketing Pharmaceutical Affairs (since September 2001)
• CEO of Laboratoire d'Analyses Médicales (Labopiette S.P.R.L.), Chief of Blood Analysis
Department and Laboratories of Clinique Antoine Depage from 1982 to 2001
• Fondator and Honorary Member, Consultant at Clinique Antoine Depage SPRL, Private
Medical Center in Brussels (since 1998)
• Pharmacist Responsible for Communication and Advertising in Besins Healthcare
Benelux (AFMPS Agr.number 274)
• Pharmacist Responsible for Phamacovigilance, past EU QPPV (AFMPS Agr.number
P244)
• Pharmacist Responsible at Besins International Healthcare (2003)
PAST CONSULTANT
CLINIQUE ANTOINE DEPAGE
Clinical Chemistry & Endocrinology departement
101, Avenue Henri Jaspar
B-1060 Brussels. BELGIUM
PUBLICATIONS
Piette P. Doyen G. Etude de l'évolution des paramètres de biologie clinique (biochimiques
enzymologiques et hormonologiques) chez des sujets participants à une compétition sportive
d'endurance, le rallye Paris-Alger-Dakar. Collège des Médecins de l'Agglomération Bruxelloise
1983: 57-62.
Piette P. Surveillance biologique des concurrents du rallye Paris-Alger-Dakar édition 1984
3è Congrès International de Médecine et Traumatologie du Sport 1984 ; 69-70.
Piette P. Traitement substitutif hormonal de la Ménopause. Pourquoi une approche
physiologique? Contraception-Fertilité-Sexualité 1991 ; 5(1): 19-26.
Dombrowicz D, Piette P, Wesel S. Efficacité clinique et tolérance métabolique d'un gel
percutané de 17 beta-estradiol dans le traitement de la ménopause. Fertilité-ContraceptionSexualité 1988; 2(1): 3-8.
Piette P. et B. de Lignières B. Quel avenir pour le Traitement Hormonal Substitutif (T.H.S.) et
le risque vasculaire à la ménopause après les résultats de la W.H.I. Study» ? Influence du
progestatif associé (1ère partie). Bénéfices et risques vasculaires d’une hormonothérapie
substitutive (2ème partie). Gunaikeïa 2002 Oct – Nov.
Piette P. The history of natural progesterone, the never-ending story. Climacteric. 2018 ;21(4):
308-314. doi: 10.1080/13697137.2018.1462792.
Piette P. The pharmacodynamics and safety of progesterone. Best Pract Res Clin Obstet
Gynaecol 2020 Jun 25: S1521-6934(20)30092-4.
Piette PCM. Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019:
ovarian stimulation for IVF/ICSI. Hum Reprod Open 2021 Mar 3;2021(1):hoab005.
doi: 10.1093/hropen/hoab005.
Piette Paul. Meta-analysis and randomized controlled studies: what clinicians should know to
prevent regular and spontaneous miscarriages of unexplained genesis? Reprod Endocrinol
2021; 61: 329-44. DOI: https://doi.org/10.18370/2309-4117.2021.61.39-44
PROFESSIONAL MEMBERSHIPS
Member of the International Menopause Society (IMS)
Member of the ESHRE
Member of the Aging Male Society
Member of US Endocrine Society
Member of the Belgian Menopause Society
Member of the Belgian Bone Club
MISCELLANEOUS
Video tape realisation and production on Hormone Replacement Therapy "Menopause",
7
th International Congress on the Menopause, Stockholm, June 1993
Principal Monitor in clinical trials, more especially related to transdermal estradiol and
micronized natural progesterone
Redactor and reviewer in a lot of HRT publications
Reviewer for peer-reviewed international journals: The Aging Male, Climacteric, The Journal
of Maternal-Fetal & Neonatal Medicine